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A B S T R A C T
In order to develop new bioactive calcium phosphate (CaP) materials to repair bone defects, it is important to
ensure these materials more closely mimic the non-stoichiometric nature of biological hydroxyapatite (HA).
Typically, biological HA combines various CaP phases with diﬀerent impurity ions, which substitute within the
HA lattice, including strontium (Sr2+), zinc (Zn2+), magnesium (Mg2+), carbonate (CO32-) and ﬂuoride (F-), but
to name a few. In addition to this biological HA have dimensions in the nanometre (nm) range, usually 60 nm in
length by 5–20 nm wide. Both the eﬀects of ion substitution and the nano-size crystals are seen as important
factors for enhancing their potential biofunctionality. The driving hypothesis was to successfully synthesise
nanoscale hydroxyapatite (nHA), co-substituted with strontium (Sr2+) and zinc (Zn2+) ions in varying con-
centrations using an aqueous precipitation method and to understand their chemical and physical properties.
The materials were characterised using Fourier Transform Infrared Spectroscopy (FTIR), X-Ray Diﬀraction
(XRD), X-Ray Photoelectron Spectroscopy (XPS) and Transmission Electron Microscopy (TEM) techniques. The
FTIR, XRD and XPS results conﬁrmed that the nHA was successfully co-substituted with Sr2+ and Zn2+, re-
placing Ca2+ within the nHA lattice at varying concentrations. The FTIR results conﬁrmed that all of the samples
were carbonated, with a signiﬁcant loss of hydroxylation as a consequence of the incorporation of Sr2+ and Zn2+
into the nHA lattice. The TEM results showed that each sample produced was nano-sized, with the Sr/Zn-10%
nHA having the smallest sized crystals approximately 17.6± 3.3 nm long and 10.2±1.4 nm wide. None of the
materials synthesised here in this study contained any other impurity CaP phases. Therefore, this study has
shown that co-substituted nHA can be prepared, and that the degree of substitution (and the substituting ion) can
have a profound eﬀect on the attendant materials’ properties.
1. Introduction
Synthetic hydroxyapatite (HA) [Ca10(PO4)6(OH)2] has been used
extensively as a bone augmentation biomaterial, producing scaﬀolds for
bone tissue engineering and for coating implants to promote bone
healing and more eﬀectively enhancing osseointegration [1,2]. It is well
understood that nanoscale hydroxyapatite (nHA) with an average par-
ticle size of less than 20 nm can optimise the biofunctionality and
bioactivity of HA, by increasing osteoblast cell proliferation [2].
Typically, biological apatite is non-stoichiometric and incorporates
various impurity ions within the HA crystal lattice, Table 1 summarises
the numerous substitutions which can occur, of those listed strontium
and zinc have been shown to add signiﬁcant enhancements to the
properties of the HA individually. However, it has been suggested that
co-substitutes of strontium and zinc could deliver a range of signiﬁcant
beneﬁts over single ion substitutes [3,4]. Strontium and zinc co-
substituted within the nHA lattice can optimise osteoconductivity by
assisting new bone growth and improve osteoinductivity, by encoura-
ging the diﬀerentiation of mesenchymal stem cells to osteoblasts, which
could work eﬀectively to prevent osteoporosis [5–7]. Both ions have
also been found to produce an antimicrobial response and zinc in par-
ticular may inhibit the growth of Streptococcus mutans, Staphylococcus
aureus, Escherichia coli and Candida albicans [8,9]. Therefore, both ions
co-substituted together may also provide an eﬀective antimicrobial
treatment to combat conditions such as osteomyelitis [8].
The driving hypothesis of this work was to successfully synthesise
nHA in a stoichiometric form, along with nHA co-substituted with Sr2+
and Zn2+ ions at a range of diﬀerent weight percentage(wt%) con-
centrations, Sr/Zn-2.5%nHA, Sr/Zn-5%nHA and Sr/Zn-10%nHA. From
previous research, one would expect the crystallinity, particle mor-
phology and phase purity to vary as the level of ionic co-substitution
was increased from 2.5% to 5–10%Sr/Zn [10,11]. Each sample was
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characterised and compared to the stoichiometric nHA using X-ray
Diﬀraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR), X-
ray Photoelectron Spectroscopy (XPS) and Transmission Electron Mi-
croscopy (TEM). To the best of our knowledge, this paper represents
one of the ﬁrst attempts to produce, systematically characterise and
compare the physicochemical properties of nano-hydroxyapatite, co-
substituted to these various Sr2+/Zn2+ combined weight percentages,
produced under identical conditions of pH and temperature.
2. Materials and methods
The nomenclature used to describe each of the calcium phosphate
(CaP) powders synthesised in this study (using a standard aqueous
precipitation method) are outlined in Table 2. Identical experimental
conditions of temperature (60 °C) and pH≥ 9, were used to synthesise
pure nanoscale hydroxyapatite (nHA), nanoscale Sr(1.25%)/Zn(1.25%)
hydroxyapatite (Sr/Zn-2.5%nHA), nanoscale Sr(2.5%)/Zn(2.5%) hy-
droxyapatite (Sr/Zn-5%nHA) and nanoscale Sr(5%)/Zn(5%) hydro-
xyapatite (Sr/Zn-10%nHA). Sodium hydroxide was used as a buﬀer to
raise the pH ≥9 for the co-substitutions, Sr/Zn-2.5%nHA, Sr/Zn-5%
nHA and Sr/Zn-10%nHA. The experimental ratios of Ca/P and (Ca +
M)/P, (where M = Sr or Zn) were maintained at 1.67, for ﬁnal com-
parison.
2.1. Aqueous precipitation synthesis of nHA
nHA powders were synthesised using an acid-base reaction of cal-
cium hydroxide (Ca(OH)2 – Sigma Aldrich) and phosphoric acid (85 wt
% H3PO4 – Sigma Aldrich). Ca(OH)2 was suspended in 500ml of
deionised H2O, heated to 60 °C and stirred at 400 rpm for 1 h. An
aqueous solution of H3PO4 was prepared by dissolving 85wt% H3PO4
in 500ml of deionised H2O. The H3PO4 solution was added to the Ca
(OH2) solution at a rate of 3.5 ml/min using a peristalic pump. The
solution was stirred for a further 2 h and allowed to settle and cool
overnight. The pH of the solution was measured at 9.1. The precipitate
was washed 3 times using deionised H2O and then dried at 60 °C in an
oven for 24 h.
2.2. Aqueous precipitation synthesis of strontium and zinc co-substituted
nHA
Starting suspensions were prepared by dissolving calcium nitrate
tetrahydrate (Ca(NO3)4·4H2O – puriss.pa Sigma Aldrich) with both
strontium nitrate (Sr(NO3)2·4H2O – puriss pa. Sigma Aldrich) and zinc
nitrate hexahydrate (Zn(NO3)2·H2O – Sigma Aldrich) in 500ml of
deionised H2O. The solution was stirred for 1 h at 60 °C and 400 rpm.
An aqueous solution of H3PO4 was prepared by dissolving 85wt%
H3PO4 in 500ml of deionised H2O. The H3PO4 solution was added to
the Ca(NO3)2·4H2O solution at a rate of 3.5ml/min using a peristalic
pump. The pH of each solution was typically measured between 2.0 and
2.5, with the solutions remaining colourless. On addition of the sodium
hydroxide to buﬀer each co-substituted solution to a pH ≥10, a white
precipitate formed immediately. The solution was stirred for a further
2 h, with the pH maintained at ≥ 10 (by further addition of sodium
hydroxide). The solution was allowed to settle and cool to room tem-
perature overnight. The formed precipitate was washed 3 times using
deionised H2O and then dried at 60 °C in an oven for 24 h.
2.3. Characterisation of the nHA and co-substituted Sr/Zn-nHA powders
X-ray Diﬀraction (XRD) of the samples was carried out using a
Bruker D8 Discover Diﬀractometer ﬁtted with a Gobel mirror.
Diﬀraction scans were obtained using a Cu Kα X-ray radiation (λ =
1.540 Å) source, with a tube voltage of 40 kV and tube current of
40mA. Each diﬀraction scan was recorded at 2θ values from 5° to 70°,
in 0.04° stepped increments, with a scan dwell time of 10 s for each
increment.
Fourier Transform Infrared (FTIR) spectroscopy scans were obtained
for each sample using a BIORAD FTS 3000MX Excalibur series instru-
ment with a PIKE Diﬀuse Reﬂectance Infrared Fourier Transform
Spectroscopy (DRIFTS) accessory. Samples were studied in absorbance
mode from 4000 to 400 cm−1, at a resolution of 4 cm−1, with 20 scans
per sample.
X-ray Photoelectron Spectroscopy (XPS) was performed using a
Kratos Axis Ultra DLD Spectrometer. Spectra were analysed using
monochromated Al Kα X-rays (hѵ= 1486.6 eV (eV)) operating at 10 kV
and 15mA (150W). During analysis, a hybrid lens mode was used
(electrostatic and magnetic) with a 300 µm × 700 µm analysis area.
Wide energy survey scans (WESS) were taken at a pass energy of
160 eV, with high resolution spectra recorded at a pass energy of 20 eV.
A Kratos charge neutraliser system with a ﬁlament current of 1.95 A
and a charge balance between 3.3.3 V and 3.6 V, was used for all
samples. Sample charging eﬀects on the calculated BE positions were
adjusted by setting the lowest BE component of the C1s spectral en-
velope to 285.0 eV, which is the generally accepted value for ad-
ventitious carbon surface contamination [12]. In total 3 areas were
analysed upon each sample and a linear background was subtracted
from each XPS spectra. The peak area of the most intense spectral lines
for each elemental species was used to determine the percentage atomic
concentration.
Transmission Electron Microscopy (TEM) observations were carried
out using a JEOL 2100f microscope operated at 200 kV. Bright-ﬁeld
images were recorded from the powders supported on carbon ﬁlms for
size analysis. ImageJ software was utilised to measure the dimensions
of 30 nanocrystals from each sample across 6 diﬀerent TEM images. The
results are reported as the mean± standard deviation.
2.4. Statistical analysis
The statistical analysis for the TEM data was performed with
GraphPad Prism version 5.00 for Windows, GraphPad Software, San
Diego California USA. One way analysis of variance (ANOVA) was used
Table 2
Nomenclature used to describe samples for the study.
Sample name Abbreviation
used
Chemical formula Molar quantity (mmol)
Ca(OH2) H3PO4 Ca(NO3)2·4H2O Sr(NO3)2·4H2O Zn(NO3)2·
H2O
Synthesised Nanoscale Hydroxyapatite nHA Ca10(PO4)6(OH)2 50.000 29.900 – – –
Synthesised Nanoscale Sr/Zn co- substituted
Hydroxyapatite (1.25%/1.25%)
Sr/Zn-2.5%nHA Ca9.75Sr0.125Zn0.125(PO4)6(OH)2 – 29.900 48.750 0.625 0.625
Synthesised Nanoscale Sr/Zn co- substituted
Hydroxyapatite (2.5%/2.5%)
Sr/Zn-5%nHA Ca9.5Sr0.25Zn0.25(PO4)6(OH)2 – 29.900 47.500 1.250 1.250
Synthesised Nanoscale Sr/Zn co- substituted
Hydroxyapatite (5%/5%)
Sr/Zn-10%nHA Ca9Sr0.5Zn0.5(PO4)6(OH)2 – 29.900 45.000 2.500 2.500
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to compare mean values in order to determine equivalence of variance
between pairs of samples. Signiﬁcance between groups was determined
using the Bonferroni multiple comparison test. A value of P< .05 was
taken as statistically signiﬁcant.
3. Results
3.1. XRD
The comparative XRD patterns for the nHA, Sr/Zn2.5%nHA, Sr/
Zn5%nHA and Sr/Zn10%nHA are shown in Fig. 1(a)–(d). The diﬀrac-
tion pattern for the nHA material is given in Fig. 1(a) and closely cor-
relates to the International Centre for Diﬀraction Data (ICDD) ﬁle # 00-
09-0432 for hydroxyapatite (HA). The peak positions and intensities
recorded clearly indicate that the nHA material contains no detectable
impurity phases. Fig. 1(b)–(d) for the Sr/Zn2.5%nHA, Sr/Zn5%nHA
and Sr/Zn10%nHA samples, respectively, show diﬀraction peaks that
are poorly resolved, indicating that each of the synthesised materials
are nanoscale (≤ 100 nm), and/or have appreciable levels of sub-
stitutions within the nHA lattice, whereby Sr2+ and Zn2+ are sub-
stituting for Ca2+. All 3 substituted nHA samples, Sr/Zn2.5%nHA, Sr/
Zn5%nHA and Sr/Zn10%nHA exhibit noticeable shifts in XRD peak
positions to lesser 2θ values, causing individual peak movement to the
left, this is highlighted in Fig. 1 with movement of the 002 peak
highlighted.
3.2. FTIR
FTIR spectra of the synthesised nHA and substituted nHA powders
are shown in Fig. 2(a)–(d), respectively. Typical P-O stretching vibra-
tions are clearly seen between 1200 and 900 cm−1, while O-P-O
bending vibrations can be observed between 610 and 400 cm−1 for
each of the diﬀerent materials [13]. O-H stretching and librational
bands are also clearly visible around 3570 cm−1 and 632 cm−1, re-
spectively [14,15]. In addition to these vibrational bands, carbonate
peaks (CO32-) can also be observed between 1550 and 1400 cm−1 and
around 870 cm−1 [16]. The carbonate peak positions may indicate that
these diﬀerent materials (both nHA and substituted nHA) have CO32-
ion substitutions at both the OH- (A-site) and PO43- (B-site) positions
[13].
3.3. XPS
Figs. 3–6 show typical XPS wide energy survey scans (WESS) and
high resolution scans recorded as B.E. (e.V.) versus intensity (counts),
respectively, for the nHA, Sr/Zn-2.5%nHA, Sr/Zn-5%nHA and Sr/
Zn10%nHA powders (namely the Ca2p, P2s, Sr3p and Zn2p peaks for
each sample). Tables 3 and 4 quantify the XPS results recorded here.
The main peaks recorded for the nHA sample were Ca2p3/2 (347.2 eV),
P2p (133.7 eV), P2s (190.9 eV), and O1s (531.6 eV) are all clearly evi-
dent. The peak positions are as expected from previous reports, how-
ever, the Ca/P ratio was slightly lower than the expected 1.67 for
stoichiometric HA, at 1.61±0.04 as highlighted in Table 3
[13,15,17,18]. For all 3 substituted samples, the Ca/P ratios were cal-
culated at 1.53±0.06 for Sr/Zn-2.5%nHA, 1.42±0.03 for Sr/Zn-5%
nHA and 1.38±0.01 for Sr/Zn-10%nHA, all of which are lower than
1.67 for stoichiometric HA. However, this is as expected and would be a
consequence of the substitution of strontium and zinc for calcium
within the nHA lattice [19–21].
As all 3 co-substituted samples contain strontium, it should be noted
that the spectral envelope observed around 133.5 eV comprises an
overlap of the Sr3d and P2p peaks as the Sr3d5/2 (133±0.5 eV), Sr3d3/
2 (135± 0.5 eV) and the P2p (132–133 eV) lines are positioned very
close together. Therefore, to quantify the phosphorus and strontium
atomic concentration % values in this study for all 3 co-substituted
samples, the P2s and Sr3p peaks are used instead of the P2p and Sr3d
peaks. The main peaks recorded for all 3 co-substituted samples, shown
in Table 4 were therefore Ca2p3/2 (346.5–347.0 eV), P2s
(190.0–190.3 eV), O1s (530.5–531.0 eV), Sr3p3/2 (268.3–268.8 eV),
Zn2p3/2 (1021.7–1022.0 eV) and Na1s (1071.0–1071.5 eV). The Sr3p3/2
peaks conﬁrm the presence and successful substitution of strontium for
calcium within each co-substituted sample and the Zn2p3/2 peaks
conﬁrm the presence and successful substitution of zinc for calcium
within each co-substituted sample.
3.4. TEM
The TEM images shown in Fig. 7 conﬁrm that the nHA, Sr/Zn-2.5%
nHA, Sr/Zn-5%nHA and Sr/Zn-10%nHA samples produced were all on
the nanoscale, with the nHA crystals measuring 99.5±12.9 nm in
length and 33.8± 7.8 nm in breadth, with an aspect ratio of
Fig. 1. XRD scans for nHA and co-substituted nHA samples.
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Fig. 2. FTIR spectra for nHA and co-substituted nHA samples.
Fig. 3. XPS spectra for nHA sample.
Sr3p3/2
Sr3p1/2
Sr3p
Zn2p
Zn2p3/2Zn2p1/2 C1s
Fig. 4. XPS spectra for Sr/Zn2.5%nHA sample.
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3.09±0.75, as reported in Table 5. The Sr/Zn-2.5%nHA, Sr/Zn-5%HA
and Sr/Zn-10%nHA samples all have nanocrystals, which are much
smaller in size (both in length and breadth) than the nHA powder, as
reported in Table 5, with typically lengths< 40 nm and breadths<
11 nm. The analysis of the TEM results, as highlighted in Fig. 8, show
that there is a statistical diﬀerence in the length and breadth of the
nHA, when compared with the co-substituted materials. In addition,
within the co-substituted materials signiﬁcant diﬀerences are observed
in the length of the crystals between all samples. With respect to the
aspect ratio, there was a signiﬁcant diﬀerence between the nHA and the
Sr/Zn-5%HA and Sr/Zn-10%nHA samples (and between all of the dif-
ferent co-substituted materials). However, no signiﬁcant statistical
diﬀerence was observed in the aspect ratio between the nHA and the
Sr/Zn-2.5%nHA sample.
4. Discussion
4.1. XRD
The XRD diﬀraction patterns for all 3 co-substituted samples, Sr/
Zn2.5%nHA, Sr/Zn5%nHA and Sr/Zn10%nHA in Fig. 1(b)–(d), show
deﬁnite peak shifts to the left indicating that the diﬀraction peaks have
shifted to slightly lower 2 theta (2θ) values, in comparison to the nHA
sample. This is due to Sr2+ ions with a larger ionic radius (1.12Ᾰ) re-
placing Ca2+ ions with a smaller ionic radius (0.99Ᾰ). It can also be
observed in the 002 peaks in Fig. 1 that as the wt% substitution of
Fig. 5. XPS spectra for Sr/Zn5%nHA sample.
Fig. 6. XPS spectra for Sr/Zn10%nHA sample.
Table 3
Comparative XPS ratios for standard nHA and substituted nHA powders (± standard deviation).
Sample Ratios
Ca/P (Ca + Sr)/P (Ca + Zn)/P (Ca + Sr + Zn)/P Sr/(Sr + Ca) Zn/(Zn + Ca) Sr + Zn/(Sr + Zn + Ca)
nHA 1.61± 0.04 – – – – – –
Sr/Zn-2.5%nHA 1.53± 0.06 1.59± 0.05 1.56± 0.06 1.63± 0.05 0.04± 0.01 0.02± 0.01 0.06± 0.01
Sr/Zn-5%nHA 1.42± 0.03 1.50± 0.04 1.47± 0.04 1.54± 0.05 0.05± 0.01 0.03± 0.01 0.08± 0.01
Sr/Zn-10%nHA 1.38± 0.01 1.55± 0.01 1.45± 0.04 1.63± 0.04 0.11± 0.01 0.05± 0.01 0.15± 0.02
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strontium increases, from Fig. 1(b)–(d), so does the level of shifting to
the left and lower 2θ values increase, suggesting that gradually larger
amounts of strontium have been successfully substituted into the nHA
with each sample. The peaks also exhibited signiﬁcant broadening with
increasing Sr2+ content as can be seen in Fig. 1(b)–(d). Again, this
result would be expected as increased Sr2+ substitution increases the
strain within the lattice [3,22,23]. The XRD peak broadenings found in
the 3 co-substituted samples may also indicate the successful substitu-
tion of Zn2+ ions for Ca2+ ions within the nHA lattice. However, peak
positions would be expected to shift very slightly to higher 2θ values,
indicating the substitution of the smaller Zn2+ ion for the Ca2+ ion
within the HA crystal lattice, causing a shrinkage in unit cell para-
meters. A peak shift to the right and higher 2θ values cannot be ob-
served in Fig. 1 but this could be due to the shift to the left and lower 2θ
values caused by the Sr2+ substitution within the same samples,
masking any subsequent peak shift to the right caused by substituted
Zn2+ ions. Previous research substituting HA with zinc alone has pro-
duced XRD diﬀraction patterns with these noticeable peak shifts to the
right and higher 2θ values, which could be used to conﬁrm along with
XPS data that Zn2+ ions have been successfully substituted within the
nHA lattice however the larger amounts of Sr2+ ions substituted within
the nHA lattice conceal any peak shift or increase in 2θ value associated
with Zn2+ substitution [10,24,25].
4.2. FTIR
The FTIR peak positions observed for the nHA material for the P-O
stretching and O-P-O bending vibrations were similar to those pre-
viously known for HA, as were those observed for the O-H librational
and stretching modes. No peaks indicative of HPO42- functional groups
were detected for the nHA material (typically peaks for HPO42- are seen
around 1120 and 580 cm−1) [17,19].
The 3 co-substituted samples appear to have broader P-O stretching
bands located around 1099, 1043 and 964, and the O-P-O bending
bands at 603 and 565, which could be due to both Sr2+ and Zn2+
substituting for calcium in the nHA lattices. There is also increased
CO32- substitution, in all 3 co-substituted samples, which previous lit-
erature has highlighted as an expected outcome when Zn2+ substitutes
for Ca2+ in the nHA lattice [25,26]. In addition to these results, O-H
stretching bands located around 3570 cm−1 and O-H librational bands
around 632 cm−1 reduce in intensity for all 3 co-substituted samples in
comparison to the nHA sample. This de-hydroxylation supports the fact
that substitution of Sr2+ and Zn2+ ions for Ca2+disrupts the nHA lat-
tice.
Table 4
XPS peak positions for standard HA and substituted HA powders.
Sample Peak positions – B.E. (eV)
C1s O1s Ca2p3/2 P2p P2s Sr3p3/2 Zn2p3/2 Na1s
nHA 285.0 531.6 347.2 133.7 190.9 – – –
Sr/Zn-2.5%nHA 285.0 530.5 346.5 132.8 190.0 268.3 1021.7 1071.0
Sr/Zn-5%nHA 285.0 530.7 346.5 132.7 190.0 268.7 1021.7 1071.3
Sr/Zn10%nHA 285.0 531.0 347.0 133.0 190.3 268.8 1022.0 1071.5
Fig. 7. TEM images of nHA and co-substituted nHA samples.
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4.3. XPS
The Ca/P ratio for the nHA sample was 1.61± 0.04, slightly lower
than the expected 1.67 for stoichiometric HA. All 3 co-substituted
samples had further reduced Ca/P ratios, 1.53± 0.06 for Sr/Zn-2.5%
nHA, 1.42± 0.03 for Sr/Zn-5%nHA and 1.38± 0.01 for Sr/Zn-10%
nHA. This reduction in calcium content for each co-substituted sample
would suggest successful substitution of strontium and zinc for calcium
within the co-substituted nHA lattices, also as the wt% of strontium and
zinc increases from 2.5%, 5% and 10%, the Ca/P ratio decreases, sug-
gesting gradually more is substituted into the nHA, replacing calcium.
The (Ca + Sr)/P ratios for each co-substituted sample, found in
Table 3 are as follows; 1.59± 0.05 for Sr/Zn-2.5%nHA, 1.50±0.04 for
Sr/Zn-5%nHA and 1.55± 0.01 for Sr/Zn-10%nHA. It can be seen that
for each sample the ratio is larger for (Ca + Sr)/P in comparison to the
Ca/P ratios alone, providing further evidence that for each co-sub-
stituted sample strontium has been successfully substituted for calcium
within the nHA lattice. Again, the 3 (Ca + Zn)/P ratios for the co-
substituted samples, Table 3 are as follows; 1.56±0.06 for Sr/Zn-2.5%
nHA, 1.47± 0.04 for Sr/Zn-5%nHA and 1.45± 0.04 for Sr/Zn-10%
nHA. This would again conﬁrm that zinc has successfully substituted for
calcium within the nHA lattice as all 3 (Ca/Zn)/P ratios are larger than
the previous Ca/P ratios for each corresponding co-substituted sample.
This is again conﬁrmed with the 3 co-substituted samples (Ca + Sr +
Zn)/P ratios, found in Table 3 which are; 1.63±0.05 for Sr/Zn-2.5%
nHA, 1.54± 0.05 for Sr/Zn-5%nHA and 1.63± 0.04 for Sr/Zn-10%
nHA, which are again larger ﬁgures than the previous Ca/P, (Ca + Sr)/
P and (Ca + Zn)/P ratios for each individual sample, again conﬁrming
the successful substitution of both strontium and zinc for calcium
within each nHA lattice.
The Sr/(Sr + Ca) ratios found in Table 3 are interesting as they
show a clear increase in strontium substitution for each increasing wt%
sample, therefore, for Sr/Zn-2.5%nHA, 0.04± 0.01, for Sr/Zn-5%nHA,
0.05±0.01 and for Sr/Zn-10%nHA, 0.11±0.01. This data indicates
that as the wt% concentration of strontium is increased from 1.25% to
2.5% to 5% for each co-substituted sample the subsequent percentage
ratios of atomic concentration also increase accordingly, conﬁrming
that as a larger percentage concentration of strontium is added at the
beginning of the reaction, a larger amount of strontium is substituted
for calcium within the nHA lattice of each sample. A similar trend can
be seen with the Zn/(Zn + Ca) ratios again located in Table 3, a clear
increase in zinc substitution for each increasing wt% sample can be
seen, for Sr/Zn-2.5%nHA, 0.02±0.01, for Sr/Zn-5%nHA, 0.03± 0.01
and for Sr/Zn-10%nHA, 0.05± 0.01. This would again indicate that as
the wt% concentration of zinc is increased from 1.25%, 2.5% to 5% for
each co-substituted sample the subsequent percentage ratios of atomic
concentration also increase, again conﬁrming that as a larger percen-
tage concentration of zinc is added at the beginning of each synthesis, a
larger amount of zinc is substituted for calcium within the nHA lattice
of each sample. Again, the Sr + Zn/(Sr + Zn + Ca) ratios for Sr/Zn-
2.5%nHA, 0.06±0.01, for Sr/Zn-5%nHA, 0.08± 0.01 and for Sr/Zn-
10%nHA, 0.15± 0.02 agree with the strontium and zinc ratios and
show a distinct rise in % atomic concentration, as the starting percen-
tage concentrations of both strontium and zinc are increased. This in-
dicates that a larger amount of both strontium and zinc has been co-
substituted into the nHA lattice of each sample, as the starting con-
centrations of strontium and zinc increase from 1.25% to 2.5% to 5%
for each ion. This suggests that the wet precipitation synthesis suc-
cessfully substitutes larger concentrations of both strontium and zinc
within the nHA lattice as amounts of the starting strontium nitrate and
zinc nitrate hexahydrate are increased.
Small amounts of sodium were also detected in the XPS spectra
analyses, with the Na1s peak located between 1071.0 and 1071.5 eV for
all 3 co-substituted samples. This was caused by the use of sodium
hydroxide as a buﬀer to increase the pH above 10 during each pre-
cipitation reaction and has been found to encourage the substitution of
zinc for calcium within the nHA lattice. It should be noted that XPS is a
surface analytical technique and only penetrates the uppermost surface
(1–10 µm) of each sample.
4.4. TEM
The TEM results show clearly that as the co-substituted wt% of
strontium and zinc increased from 2.5, 5 to 10%, the average particle
length for each sample reduced from 31.4±6.5 nm, 23.0± 3.0 nm and
17.6±3.3 nm, respectively with the breadth remaining relatively
constant at 9.5± 1.5 nm, 10.0± 1.5 nm and 10.2±1.4 nm, respec-
tively. This corresponds with previous research which showed that nHA
substituted with both strontium and zinc produced smaller sized par-
ticle samples [27,28]. It has also been reported in previous literature
that as the concentration of the substituted ion rises, regardless of
Table 5
Dimensions of nanocrystals (± standard deviation) measured using TEM analysis and
processed using ImageJ software.
Sample nHA Sr/Zn-2.5%-
nHA
Sr/Zn-5%-nHA Sr/Zn-10%-
nHA
Length
(nm)
99.5±12.9 31.4±6.5 23.0± 3.0 17.6± 3.3
Breadth
(nm)
33.8±7.8 9.5± 1.5 10.0± 1.5 10.2± 1.4
Aspect ratio 3.09±0.75 3.40±0.96 2.36± 0.47 1.75± 0.33
Fig. 8. TEM statistical comparisons between nHA and co-substituted Sr/Zn nHA samples. *** Statistically signiﬁcant at P< .0001 in comparison with the control nHA.
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whether it is strontium or zinc, the subsequent substituted nHA crystals
tend to agglomerate [27,28]. The statistical analysis of the crystal
length, breadth and aspect ratio here, highlight that as the concentra-
tion of the co-substituted ions increase, it has an obvious eﬀect on the
growth of the crystals, (with higher ion substitutions inhibiting crystal
growth).
This study has also found that for every sample analysed using TEM,
the observed nanocrystals appeared granular in nature, which may
indicate a high level of porosity and an increased surface area within
both the nHA and substituted nHA materials synthesised. An optimised
surface nano-topography could in turn increase adsorption of speciﬁc
proteins and ultimately improve osteoblast cell adhesion and promote
osteoblast proliferation and diﬀerentiation [29]. Previous research has
also found that nano-sized HA, with a larger surface area, has increased
sinterability and densiﬁcation which can in turn improve its mechanical
properties and fracture toughness [2,29].
5. Conclusion
The speciﬁc aim of this work was to synthesise nHA and nHA co-
substituted with strontium and zinc at varying concentrations, Sr/Zn-
2.5%nHA, Sr/Zn-5%nHA and Sr/Zn-10%nHA, using an aqueous pre-
cipitation technique. The results indicated that nHA and nHA co-sub-
stituted with strontium and zinc were successfully produced at varying
concentrations. The nHA materials produced did not contain any other
CaP impurity phases and were proven to be nano-sized in scale, as
shown by XRD, FTIR, XPS and TEM analyses. Further comparison did
indicate that crystallinity did vary as the amount of Sr2+ and Zn2+
increased within the co-substituted samples, with the degree of struc-
tural order decreasing as Ca2+ ions were progressively replaced with
either larger Sr2+ or smaller Zn2+ ions with increasing dehydroxylation
observed within the co-substituted samples, which further highlighted
disruption of the HA lattice. Also, the particle morphology of the co-
substituted nHA samples changed with increased co-substitution, with
the particles steadily reducing in length.
Very few previous studies have investigated the synthesis of nHA
materials co-substituted with Sr2+ and Zn2+. Therefore, the successful
co-substitution of both strontium and zinc within nHA, as demonstrated
successfully here, could provide a more bioactive bone substitute bio-
material. However, there is a need for further detailed in vitro and in
vivo studies to conﬁrm the eﬃcacy of these co-substituted materials.
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